Drug reference
insulin degludec-liraglutide
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Drug class
Endocrine (Insulins)
Mechanism of action
Liraglutide: Glucagon-like peptide-1 (GLP-1) receptor agonist that increases glucose-dependent insulin release, decreases glucagon secretion, and slows gastric emptying, Insulin degludec: Regulates glucose metabolism
Common side effects
- Upper respiratory tract infection
- Nasopharyngitis
- Headache
- Nausea
- Increased lipase
- Mildly elevated serum bilirubin concentrations
- Diarrhea
Related conditions
Frequently asked questions
What drug class is insulin degludec-liraglutide?
insulin degludec-liraglutide belongs to: Endocrine.
How does insulin degludec-liraglutide work?
Liraglutide: Glucagon-like peptide-1 (GLP-1) receptor agonist that increases glucose-dependent insulin release, decreases glucagon secretion, and slows gastric emptying, Insulin degludec: Regulates glucose metabolism
What are the common side effects of insulin degludec-liraglutide?
Upper respiratory tract infection, Nasopharyngitis, Headache, Nausea, Increased lipase, Mildly elevated serum bilirubin concentrations, Diarrhea
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.